There are risks associated with participating in the study, including breach of confidentiality, psychological distress caused by discussing difficult topics, and risks associated with the POD intervention. conditions: Opioid Use Disorder conditions: Chronic Pain studyType: INTERVENTIONAL phases: PHASE4 allocation: RANDOMIZED interventionModel: FACTORIAL interventionModelDescription: Participants will be stratified by recruitment clinic and dose of buprenorphine at enrollment (≤16 mg vs \>16 mg) and randomized in 2x2 factorial design: 1) either to PSM or Usual Care, and then 2) either to POD or standard buprenorphine dosing. The randomization schema will be generated by the TREETOP Data Core using a stratified permuted block design and will be integrated into the web-based data collection and management system (REDCap). primaryPurpose: TREATMENT masking: NONE count: 460 type: ESTIMATED name: Patient-Oriented Dosing (POD) name: Pain Self-Management (PSM) name: Usual Care name: Standard Buprenorphine Dosing Condition measure: Change from Baseline in Pain Interference as Assessed by the PROMIS SF v1.0 - Pain Interference 4a at 3 months Post-baseline measure: Proportion of Participants Retained in buprenorphine Treatment at 3 months Post-baseline measure: Change from Baseline in Overall Pain as Assessed by the PEG at 3 months Post-baseline measure: Change from Baseline in Pain Catastrophizing as Assessed by the Pain Catastrophizing Questionnaire-6-item at 3 months Post-baseline measure: Proportion of Participants Taking any MOUD at 3-, 6-, 9- and 12-months Post-baseline measure: Change from Baseline in Self-efficacy as Assessed by the PROMIS Self-Efficacy for Managing Symptoms SF-4a at 3 months Post-baseline measure: Number of Days Non-prescribed Opioids were Used in the past 30 days as Assessed by the Modified ASI at 3-months Post-baseline measure: Total score on the IMPOWR Opioid Misuse Screening scale at 3 months Post-baseline sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Outpatient Addiction Treatment Services (OATS) city: Baltimore state: Maryland zip: 21201 country: United States name: Research Team role: CONTACT email: HFitzsimons@som.umaryland.edu name: Eric Weintraub, MD role: PRINCIPAL_INVESTIGATOR lat: 39.29038 lon: -76.61219 facility: Alcohol and Drug Abuse Program (ADAP) - UM Addiction Treatment Center city: Baltimore state: Maryland zip: 21223 country: United States name: Research Team role: CONTACT email: HFitzsimons@som.umaryland.edu name: Eric Weintraub, MD role: PRINCIPAL_INVESTIGATOR lat: 39.29038 lon: -76.61219 facility: Comprehensive Care Practice (CCP) - Johns Hopkins Bayview Medical Center city: Baltimore state: Maryland zip: 21224 country: United States name: Research Team role: CONTACT email: TREETOP@pitt.edu name: Sophia Purekal, MD role: PRINCIPAL_INVESTIGATOR lat: 39.29038 lon: -76.61219 facility: Wells House city: Hagerstown state: Maryland zip: 21740 country: United States name: Research Team role: CONTACT email: HFitzsimons@som.umaryland.edu name: Eric Weintraub, MD role: PRINCIPAL_INVESTIGATOR lat: 39.64176 lon: -77.71999 facility: Central City Concern (CCC) city: Portland state: Oregon zip: 97209 country: United States name: Research Team role: CONTACT email: treetop@ohsu.edu name: Jonathan Robbins, MD role: PRINCIPAL_INVESTIGATOR lat: 45.52345 lon: -122.67621 facility: Recovery Works Northwest (RWNW) city: Portland state: Oregon zip: 97233 country: United States name: Research Team role: CONTACT email: treetop@ohsu.edu name: Jonathan Robbins, MD role: PRINCIPAL_INVESTIGATOR lat: 45.52345 lon: -122.67621 facility: OHSU Harm Reduction Bridges to Care (HRBR) city: Portland state: Oregon zip: 97239 country: United States name: Research Team role: CONTACT email: treetop@ohsu.edu name: Jonathan Robbins, MD role: PRINCIPAL_INVESTIGATOR lat: 45.52345 lon: -122.67621 facility: OHSU Internal Medicine Clinic (IMC) city: Portland state: Oregon zip: 97239 country: United States name: Research Team role: CONTACT email: treetop@ohsu.edu name: Jonathan Robbins, MD role: PRINCIPAL_INVESTIGATOR lat: 45.52345 lon: -122.67621 facility: UPMC Latterman Family Health Center city: McKeesport state: Pennsylvania zip: 15132 country: United States name: Research Team role: CONTACT phone: 412-852-8499 email: TREETOP@pitt.edu name: Jessica Merlin, MD, PhD, MBA role: PRINCIPAL_INVESTIGATOR lat: 40.34785 lon: -79.86422 facility: UPMC St. Margaret Family Health Center city: New Kensington state: Pennsylvania zip: 15068 country: United States name: Research Team role: CONTACT phone: 412-852-8499 email: TREETOP@pitt.edu name: Jessica Merlin, MD, PhD, MBA role: PRINCIPAL_INVESTIGATOR lat: 40.56979 lon: -79.76477 facility: UPMC Internal Medicine Recovery Engagement Program (IM-REP) city: Pittsburgh state: Pennsylvania zip: 15219 country: United States name: Research Team role: CONTACT phone: 412-852-8499 email: TREETOP@pitt.edu name: Jessica Merlin, MD, PhD, MBA role: PRINCIPAL_INVESTIGATOR lat: 40.44062 lon: -79.99589 facility: WVU Crisis Support & Recovery Center city: Martinsburg state: West Virginia zip: 25401 country: United States name: Research Team role: CONTACT phone: 304-290-9159 email: lychoo@hsc.wvu.edu name: Dorothy Van Oppen, MD role: PRINCIPAL_INVESTIGATOR lat: 39.45621 lon: -77.96389 facility: WVU Chestnut Ridge Comprehensive Addiction Treatment Program (COAT) city: Morgantown state: West Virginia zip: 26505 country: United States name: Research Team role: CONTACT phone: 304-290-9159 email: lychoo@hsc.wvu.edu name: Dorothy Van Oppen, MD role: PRINCIPAL_INVESTIGATOR lat: 39.62953 lon: -79.9559 hasResults: False